Effect of Salvia Salvianolic Acid on Cardiac Function and Hypersensitive C Reactive Protein in Patients with Acute Myocardial Infarction
10.3969/j.issn.1671-332X.2018.05.027
- VernacularTitle:丹参多酚酸盐对急性心肌梗死患者心功能及超敏C反应蛋白的影响
- Author:
Ganlin ZHU
1
;
Dongli WANG
Author Information
1. 景德镇市第二人民医院 江西 景德镇 333000
- Keywords:
Salvia Salvianolic Acid Salt;
Acute Myocardial Infarction;
Cardiac Function;
Hypersensitivity C Reactive Protein
- From:
Modern Hospital
2018;18(5):713-714,718
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of Salvia miltiorrhiza on cardiac function and hypersensitive C reactive protein in patients with acute myocardial infarction. Methods The clinical data of 80 patients with myocardial infarction admitted to our hospital from October 2016 to December 2017 were randomly selected and analyzed. They were randomly divided into control group (40 cases) and experimental group (40 cases). The control group was treated with standardized treatment. The experimental group was given salvianolic acid on this basis. Cardiac function improvement, hypersensitivity C reactive protein (hs-CRP), serum cardiac troponin I (cTnI), creatine kinase isoenzyme (CKMB) and total effective rate of two groups were compared. Results The treatment group of patients with heart function improved significantly better than the control group, the two groups have statistical significance compared to patients in the treatment group (P＜0. 05); high sensitivity C reactive protein score and serum cardiac troponin I and creatine kinase were significantly better than the control group, with statistically significant differences between data (P＜0. 05). After treatment, the total effective rate of the treatment group was 92. 50％, while that of the control group was 80％. The treatment group was significantly higher than the control group, and the data comparison was statistically significant (P＜0. 05). Conclusion Salvia salvianolic acid salt can significantly improve the cardiac function and hypersensitivity C reaction protein in patients with myocardial infarction.
